Investor Presentaiton slide image

Investor Presentaiton

Recent Highlights: Proprietary Products Our first set of NDAs Zembrace & Sernivo launched in the US 3 mg NDC 67857-809-37 Rx Only Zembrace SYMTOUCH (sumatriptan injection) For subcutaneous use only. Each autoiniector contains a profilled eurinna ac Closed three deals to In-license assets Xeglyze, XP23829 E 7777 Xeglyze (abarretapir) Xeglyze (abametapir) Lution, 0.74% www. NDC WIZ K Ax Only Sernivo (betamethasone dipropionate) Spray, 0.05% Potency expressed as be For Topical Use Only PROMIUS PHARMA GERMAN XenoPort Eisai
View entire presentation